SANA News and Press, Sana Biotechnology Inc. From 08/26/25

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will featu...

Sana Biotechnology Inc. (SANA) is expected to report $-0.2 for Q2 2025

2025-08-11 16:45:45 ET More on Sana Biotechnology Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment Sana Biotechnology drops 13% on $75M stock issuance, pr...

Presented positive 6-month clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, while continuing to function and persist with stable C-peptide New England Journal of Me...

2025-08-08 14:58:37 ET Investment Overview - Understanding Sana's Allogeneic Cell Therapy Breakthrough In Type 1 Diabetes Read the full article on Seeking Alpha For further details see: Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

A look at the top 10 most actives in the United States CIMG Inc. (IMG) rose 113.5% to $0.427 on volume of 701,755,593 shares Incannex Healthcare Inc. (IXHL) rose 34.1% to $0.4625 on volume of 275,339,019 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.6% to $7.66 on volume ...

A look at the top 10 most actives in the United States CIMG Inc. (IMG) rose 214.9% to $0.6299 on volume of 353,208,780 shares FOXO Technologies Inc. Class A (FOXO) rose 2.7% to $0.1314 on volume of 139,743,452 shares LQR House Inc. (YHC) rose 18.3% to $1.4195 on volume of 87,637,299 shares ...

2025-08-07 00:52:55 ET More on Sana Biotechnology Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment Seeking Alpha’s Quant Rating on Sana Biotechnology Historical earnings data for Sana Biotechnology Financial informat...

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has priced its underwritten public offering of 20,895,522 shares of its common stock...

SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 million of shares of its comm...